乐普医疗2025年净利同比预增223.97%—385.95%

Core Viewpoint - Lepu Medical (300003) forecasts a net profit attributable to shareholders of 800 million to 1.2 billion yuan for 2025, representing a year-on-year growth of 223.97% to 385.95% [1] Group 1: Financial Performance - The company's core business in cardiovascular interventional revenue is steadily increasing [1] - The retail channel inventory cleanup in the pharmaceutical sector is nearly complete, leading to double-digit revenue growth [1] - The traditional business foundation remains solid, providing stable profits and cash flow [1] Group 2: Strategic Developments - The strategic emerging sectors, including innovative drugs and dermatology, have contributed to performance growth [1] - The net cash flow from operating activities has increased by approximately 95% [1]